Evidence map›Paper›PMID 40996829›Full record

ArticleEuropean heart journal2026

Sex differences in atrial fibrillation-related atrial remodelling assessed by electroanatomic mapping and biopsy.

Kana Nakashima, Takanori Yamaguchi, Yuya Takahashi, Toyokazu Otsubo, Shigeki Shichida, Ryosuke Osako, Kodai Shinzato, Kotaro Tsuruta, Yuki Nishimura, Makoto Edayoshi and 11 more

Abstract read
In one paragraph

Article in European heart journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Understanding the Diseased Atria.Physiology (Bethesda, Md.) · 2026
    Review
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Kana NakashimaDepartment of Cardiovascular Medicine, Saga University, 5-1-1 Nabeshima, Saga 849-8501, Japan.ORCID 0000-0001-7298-3059
Takanori YamaguchiDepartment of Cardiovascular Medicine, Saga University, 5-1-1 Nabeshima, Saga 849-8501, Japan.ORCID 0000-0002-0613-8591
Yuya TakahashiDepartment of Cardiovascular Medicine, Saga University, 5-1-1 Nabeshima, Saga 849-8501, Japan.
Toyokazu OtsuboDepartment of Cardiovascular Medicine, Saga University, 5-1-1 Nabeshima, Saga 849-8501, Japan.
Shigeki ShichidaDepartment of Cardiovascular Medicine, Saga University, 5-1-1 Nabeshima, Saga 849-8501, Japan.
Ryosuke OsakoDepartment of Cardiovascular Medicine, Saga University, 5-1-1 Nabeshima, Saga 849-8501, Japan.
Kodai ShinzatoDepartment of Cardiovascular Medicine, Saga University, 5-1-1 Nabeshima, Saga 849-8501, Japan.
Kotaro TsurutaDepartment of Cardiovascular Medicine, Saga University, 5-1-1 Nabeshima, Saga 849-8501, Japan.
Yuki NishimuraDepartment of Cardiovascular Medicine, Saga University, 5-1-1 Nabeshima, Saga 849-8501, Japan.
Makoto EdayoshiDepartment of Cardiovascular Medicine, Saga University, 5-1-1 Nabeshima, Saga 849-8501, Japan.
Yuki KawanoDivision of Cardiology, Saiseikai Futsukaichi Hospital, Chikushino, Japan.
Yukako Shintani-DomotoDepartment of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo, Japan.
Kai MiyazakiDepartment of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo, Japan.
Akira FukuiDepartment of Cardiology and Clinical Examination, Faculty of Medicine, Oita University, Yufu, Japan.
Atsushi KawaguchiEducation and Research Center for Community Medicine, Faculty of Medicine, Saga University, Saga, Japan.ORCID 0000-0002-8911-3321
Shigehisa AokiDepartment of Pathology and Microbiology, Saga University, Saga, Japan.
Seitaro NomuraDepartments of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.
Naohiko TakahashiDepartment of Cardiology and Clinical Examination, Faculty of Medicine, Oita University, Yufu, Japan.ORCID 0000-0001-9037-0010
Kyoko SoejimaDepartment of Cardiovascular Medicine, Kyorin University School of Medicine, Tokyo, Japan.
Kaoru ItoLaboratory for Cardiovascular Genomics and Informatics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.ORCID 0000-0003-1843-773X
Koichi NodeDepartment of Cardiovascular Medicine, Saga University, 5-1-1 Nabeshima, Saga 849-8501, Japan.ORCID 0000-0002-2534-0939

Funding

Japan Agency for Medical Research and Development JP18km0405209Japan Agency for Medical Research and Development JP22ek0210164Japan Agency for Medical Research and Development JP23ek0210164Japan Agency for Medical Research and Development JP23tm0724607Japan Agency for Medical Research and Development JP24ek0109755JSPS KAKENHI Scientific Research (A) JP22H00471Scientific Research (C) JP21K08056Scientific Research (C) JP23K06434Scientific Research (C) JP23K07532
6 · The paper itself

Abstract

BACKGROUND AND

aimsHistopathological sex differences in atrial structural remodelling in patients with non-valvular atrial fibrillation (AF) require further investigation.

methodsRight atrial biopsy was performed on 282 patients undergoing AF ablation and high-density voltage mapping (66 ± 12 years; 81 women). Of the 58 patients without AF undergoing supraventricular tachycardia ablation included, 26 underwent atrial biopsy and 41 underwent voltage mapping. The voltage at the biopsy site (Vbiopsy), global left atrial voltage (VGLA), and histopathological parameters (fibrosis, intercellular space, myofibrillar loss, myocardial nuclear density, and cardiomyocyte diameter) were evaluated.

resultsVbiopsy (7.4 ± 2.6 vs 9.3 ± 3.2 mV, P < .001) and VGLA (4.9 ± 1.8 vs 6.7 ± 2.2 mV, P < .001) were significantly lower in women with AF. A similar relationship was observed in patients without AF: Vbiopsy (7.8 ± 2.7 vs 10.9 ± 2.6 mV, P < .001) and VGLA (7.3 ± 1.7 vs 9.4 ± 1.4 mV, P < .001) were lower in women. Vbiopsy and VGLA positively correlated in both groups (r = 0.70 and 0.60, P < .001), supporting an integrated interpretation of the voltage and histopathological data. No significant sex differences were observed among the histopathological parameters. In 34 patients with minimal histological change, small cardiomyocytes (<10 μm) were more frequent in women (37% ± 23% vs 20% ± 19%, P = .029).

conclusionsDespite consistently lower voltage in women, no significant histopathological sex differences were identified in non-valvular cases, likely due to their inherently smaller atrial mass.

Indexed as

Atrial FibrillationAtrial RemodelingAgedBiopsyCatheter AblationElectrophysiologic Techniques, CardiacFemaleHeart AtriaHumansMaleMiddle AgedMyocytes, CardiacSex FactorsAtrial biopsyAtrial cardiomyopathyAtrial fibrillationHistopathologySex differences

Identifiers

PMID40996829
PMCPMC12777700

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.